Influenza neuraminidase.

ABSTRACT: Influenza neuraminidase is the target of two licensed antivirals that have been very successful, with several more in development. However, neuraminidase has been largely ignored as a vaccine target despite evidence that inclusion of neuraminidase in the subunit vaccine gives increased protection. This article describes current knowledge on the structure, enzyme activity, and antigenic significance of neuraminidase.

SUBMITTER: Air GM 

PROVIDER: S-EPMC3290697 | biostudies-literature | 2012 Jul

REPOSITORIES: biostudies-literature